Idoroenyi Amanam to Antibodies, Bispecific
This is a "connection" page, showing publications Idoroenyi Amanam has written about Antibodies, Bispecific.
Connection Strength
0.427
-
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL. Blood Adv. 2025 May 13; 9(9):2159-2172.
Score: 0.229
-
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. Am J Hematol. 2023 06; 98(6):848-856.
Score: 0.197